Pharma and Health Care Industry Research Report 2023

Report ID
35084
Publisher
APO Research
Published Date
11-Aug
Delivery Format
PDF
No of Report Page
112
Editor's Rating
US $2,950.00
US $4,425.00
US $5,900.00
  • Report Details
    The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
    Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.
    In this report, we mainly study the pharma and healthcare product.
    
    Highlights
    The global Pharma and Health Care market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
    
    North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%.
    
    Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.
    
    Report Scope
    This report aims to provide a comprehensive presentation of the global market for Pharma and Health Care, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma and Health Care.
    
    The Pharma and Health Care market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pharma and Health Care market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    
    For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
    
    The report will help the Pharma and Health Care companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
    
    Key Companies & Market Share Insights
    In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
    
    Some of the prominent players reviewed in the research report include:
    
    • Johnson & Johnson
    • Novartis
    • Roche
    • AbbVie
    • Merck & Co.
    • Bristol Myers Squibb
    • GlaxoSmithKline
    • Pfizer
    • Sanofi
    • Takeda
    • AstraZeneca
    • Bayer
    • Eli Lilly & Co.
    • Gilead Sciences
    • Amgen
    • Novo Nordisk
    • Teva
    • Boehringer Ingelheim
    • Biogen
    • Astellas
    Product Type Insights Global markets are presented by Pharma and Health Care type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Pharma and Health Care are procured by the companies. This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029). Pharma and Health Care segment by Format
    • Bottle
    • Blister
    • Others
    Application Insights This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029). This report also outlines the market trends of each segment and consumer behaviors impacting the Pharma and Health Care market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Pharma and Health Care market. Pharma and Health Care Segment by Prescription
    • OTC Drugs
    • Prescription Drugs
    Regional Outlook This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029. The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
    • North America
    • United States
    • Canada
    • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
    • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
    • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
    • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
    Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. COVID-19 and Russia-Ukraine War Influence Analysis The readers in the section will understand how the Pharma and Health Care market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come. Reasons to Buy This Report This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma and Health Care market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. This report will help stakeholders to understand the global industry status and trends of Pharma and Health Care and provides them with information on key market drivers, restraints, challenges, and opportunities. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
    • This report stays updated with novel technology integration, features, and the latest developments in the market
    • This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Pharma and Health Care industry.
    • This report helps stakeholders to gain insights into which regions to target globally
    • This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma and Health Care.
    • This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
    Core Chapters Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 6: Detailed analysis of Pharma and Health Care companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 13: The main points and conclusions of the report. Frequently Asked Questions
    • What factors will challenge the Product Name market growth?
    • Which end-use segment will expand at the fastest CAGR in the Product Name market?
    • Which are the emerging players in the Product Name market?
    • How concentrated is the Product Name market?
    • Which factors are positively contributing to the Product Name market growth?
    • Which are the novel product innovations in the Product Name market?
    • Which product segment will emerge as the most lucrative in the Product Name market?
    • Which factors are increasing the competition in the Product Name market?
    • Which are the strategic measures taken by the Product Name industry players?
    • Which region will witness inactive growth during the forecast period?
    • What key trends are likely to emerge in the Product Name market in the coming years?
  • Table Of Content
    1 Preface
    1.1 Scope of Report
    1.2 Reasons for Doing This Study
    1.3 Research Methodology
    1.4 Research Process
    1.5 Data Source
    1.5.1 Secondary Sources
    1.5.2 Primary Sources
    2 Market Overview
    2.1 Product Definition
    2.2 Pharma and Health Care by Format
    2.2.1 Market Value Comparison by Format (2018 VS 2022 VS 2029)
    1.2.2 Bottle
    1.2.3 Blister
    1.2.4 Others
    2.3 Pharma and Health Care by Prescription
    2.3.1 Market Value Comparison by Prescription (2018 VS 2022 VS 2029)
    2.3.2 OTC Drugs
    2.3.3 Prescription Drugs
    2.4 Assumptions and Limitations
    3 Pharma and Health Care Breakdown Data by Format
    3.1 Global Pharma and Health Care Historic Market Size by Format (2018-2023)
    3.2 Global Pharma and Health Care Forecasted Market Size by Format (2023-2028)
    4 Pharma and Health Care Breakdown Data by Prescription
    4.1 Global Pharma and Health Care Historic Market Size by Prescription (2018-2023)
    4.2 Global Pharma and Health Care Forecasted Market Size by Prescription (2018-2023)
    5 Global Growth Trends
    5.1 Global Pharma and Health Care Market Perspective (2018-2029)
    5.2 Global Pharma and Health Care Growth Trends by Region
    5.2.1 Global Pharma and Health Care Market Size by Region: 2018 VS 2022 VS 2029
    5.2.2 Pharma and Health Care Historic Market Size by Region (2018-2023)
    5.2.3 Pharma and Health Care Forecasted Market Size by Region (2024-2029)
    5.3 Pharma and Health Care Market Dynamics
    5.3.1 Pharma and Health Care Industry Trends
    5.3.2 Pharma and Health Care Market Drivers
    5.3.3 Pharma and Health Care Market Challenges
    5.3.4 Pharma and Health Care Market Restraints
    6 Market Competitive Landscape by Players
    6.1 Global Top Pharma and Health Care Players by Revenue
    6.1.1 Global Top Pharma and Health Care Players by Revenue (2018-2023)
    6.1.2 Global Pharma and Health Care Revenue Market Share by Players (2018-2023)
    6.2 Global Pharma and Health Care Industry Players Ranking, 2021 VS 2022 VS 2023
    6.3 Global Key Players of Pharma and Health Care Head office and Area Served
    6.4 Global Pharma and Health Care Players, Product Type & Application
    6.5 Global Pharma and Health Care Players, Date of Enter into This Industry
    6.6 Global Pharma and Health Care Market CR5 and HHI
    6.7 Global Players Mergers & Acquisition
    7 North America
    7.1 North America Pharma and Health Care Market Size (2018-2029)
    7.2 North America Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 North America Pharma and Health Care Market Size by Country (2018-2023)
    7.4 North America Pharma and Health Care Market Size by Country (2024-2029)
    7.5 United States
    7.6 Canada
    8 Europe
    8.1 Europe Pharma and Health Care Market Size (2018-2029)
    8.2 Europe Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
    8.3 Europe Pharma and Health Care Market Size by Country (2018-2023)
    8.4 Europe Pharma and Health Care Market Size by Country (2024-2029)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
    9 Asia-Pacific
    9.1 Asia-Pacific Pharma and Health Care Market Size (2018-2029)
    9.2 Asia-Pacific Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Asia-Pacific Pharma and Health Care Market Size by Country (2018-2023)
    9.4 Asia-Pacific Pharma and Health Care Market Size by Country (2024-2029)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
    10 Latin America
    10.1 Latin America Pharma and Health Care Market Size (2018-2029)
    10.2 Latin America Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Latin America Pharma and Health Care Market Size by Country (2018-2023)
    10.4 Latin America Pharma and Health Care Market Size by Country (2024-2029)
    9.4 Mexico
    9.5 Brazil
    11 Middle East & Africa
    11.1 Middle East & Africa Pharma and Health Care Market Size (2018-2029)
    11.2 Middle East & Africa Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
    11.3 Middle East & Africa Pharma and Health Care Market Size by Country (2018-2023)
    11.4 Middle East & Africa Pharma and Health Care Market Size by Country (2024-2029)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
    12 Players Profiled
    11.1 Johnson & Johnson
    11.1.1 Johnson & Johnson Company Detail
    11.1.2 Johnson & Johnson Business Overview
    11.1.3 Johnson & Johnson Pharma and Health Care Introduction
    11.1.4 Johnson & Johnson Revenue in Pharma and Health Care Business (2017-2022)
    11.1.5 Johnson & Johnson Recent Development
    11.2 Novartis
    11.2.1 Novartis Company Detail
    11.2.2 Novartis Business Overview
    11.2.3 Novartis Pharma and Health Care Introduction
    11.2.4 Novartis Revenue in Pharma and Health Care Business (2017-2022)
    11.2.5 Novartis Recent Development
    11.3 Roche
    11.3.1 Roche Company Detail
    11.3.2 Roche Business Overview
    11.3.3 Roche Pharma and Health Care Introduction
    11.3.4 Roche Revenue in Pharma and Health Care Business (2017-2022)
    11.3.5 Roche Recent Development
    11.4 AbbVie
    11.4.1 AbbVie Company Detail
    11.4.2 AbbVie Business Overview
    11.4.3 AbbVie Pharma and Health Care Introduction
    11.4.4 AbbVie Revenue in Pharma and Health Care Business (2017-2022)
    11.4.5 AbbVie Recent Development
    11.5 Merck & Co.
    11.5.1 Merck & Co. Company Detail
    11.5.2 Merck & Co. Business Overview
    11.5.3 Merck & Co. Pharma and Health Care Introduction
    11.5.4 Merck & Co. Revenue in Pharma and Health Care Business (2017-2022)
    11.5.5 Merck & Co. Recent Development
    11.6 Bristol Myers Squibb
    11.6.1 Bristol Myers Squibb Company Detail
    11.6.2 Bristol Myers Squibb Business Overview
    11.6.3 Bristol Myers Squibb Pharma and Health Care Introduction
    11.6.4 Bristol Myers Squibb Revenue in Pharma and Health Care Business (2017-2022)
    11.6.5 Bristol Myers Squibb Recent Development
    11.7 GlaxoSmithKline
    11.7.1 GlaxoSmithKline Company Detail
    11.7.2 GlaxoSmithKline Business Overview
    11.7.3 GlaxoSmithKline Pharma and Health Care Introduction
    11.7.4 GlaxoSmithKline Revenue in Pharma and Health Care Business (2017-2022)
    11.7.5 GlaxoSmithKline Recent Development
    11.8 Pfizer
    11.8.1 Pfizer Company Detail
    11.8.2 Pfizer Business Overview
    11.8.3 Pfizer Pharma and Health Care Introduction
    11.8.4 Pfizer Revenue in Pharma and Health Care Business (2017-2022)
    11.8.5 Pfizer Recent Development
    11.9 Sanofi
    11.9.1 Sanofi Company Detail
    11.9.2 Sanofi Business Overview
    11.9.3 Sanofi Pharma and Health Care Introduction
    11.9.4 Sanofi Revenue in Pharma and Health Care Business (2017-2022)
    11.9.5 Sanofi Recent Development
    11.10 Takeda
    11.10.1 Takeda Company Detail
    11.10.2 Takeda Business Overview
    11.10.3 Takeda Pharma and Health Care Introduction
    11.10.4 Takeda Revenue in Pharma and Health Care Business (2017-2022)
    11.10.5 Takeda Recent Development
    11.11 AstraZeneca
    11.11.1 AstraZeneca Company Detail
    11.11.2 AstraZeneca Business Overview
    11.11.3 AstraZeneca Pharma and Health Care Introduction
    11.11.4 AstraZeneca Revenue in Pharma and Health Care Business (2017-2022)
    11.11.5 AstraZeneca Recent Development
    11.12 Bayer
    11.12.1 Bayer Company Detail
    11.12.2 Bayer Business Overview
    11.12.3 Bayer Pharma and Health Care Introduction
    11.12.4 Bayer Revenue in Pharma and Health Care Business (2017-2022)
    11.12.5 Bayer Recent Development
    11.13 Eli Lilly & Co.
    11.13.1 Eli Lilly & Co. Company Detail
    11.13.2 Eli Lilly & Co. Business Overview
    11.13.3 Eli Lilly & Co. Pharma and Health Care Introduction
    11.13.4 Eli Lilly & Co. Revenue in Pharma and Health Care Business (2017-2022)
    11.13.5 Eli Lilly & Co. Recent Development
    11.14 Gilead Sciences
    11.14.1 Gilead Sciences Company Detail
    11.14.2 Gilead Sciences Business Overview
    11.14.3 Gilead Sciences Pharma and Health Care Introduction
    11.14.4 Gilead Sciences Revenue in Pharma and Health Care Business (2017-2022)
    11.14.5 Gilead Sciences Recent Development
    11.15 Amgen
    11.15.1 Amgen Company Detail
    11.15.2 Amgen Business Overview
    11.15.3 Amgen Pharma and Health Care Introduction
    11.15.4 Amgen Revenue in Pharma and Health Care Business (2017-2022)
    11.15.5 Amgen Recent Development
    11.16 Novo Nordisk
    11.16.1 Novo Nordisk Company Detail
    11.16.2 Novo Nordisk Business Overview
    11.16.3 Novo Nordisk Pharma and Health Care Introduction
    11.16.4 Novo Nordisk Revenue in Pharma and Health Care Business (2017-2022)
    11.16.5 Novo Nordisk Recent Development
    11.17 Teva
    11.17.1 Teva Company Detail
    11.17.2 Teva Business Overview
    11.17.3 Teva Pharma and Health Care Introduction
    11.17.4 Teva Revenue in Pharma and Health Care Business (2017-2022)
    11.17.5 Teva Recent Development
    11.18 Boehringer Ingelheim
    11.18.1 Boehringer Ingelheim Company Detail
    11.18.2 Boehringer Ingelheim Business Overview
    11.18.3 Boehringer Ingelheim Pharma and Health Care Introduction
    11.18.4 Boehringer Ingelheim Revenue in Pharma and Health Care Business (2017-2022)
    11.18.5 Boehringer Ingelheim Recent Development
    11.19 Biogen
    11.19.1 Biogen Company Detail
    11.19.2 Biogen Business Overview
    11.19.3 Biogen Pharma and Health Care Introduction
    11.19.4 Biogen Revenue in Pharma and Health Care Business (2017-2022)
    11.19.5 Biogen Recent Development
    11.20 Astellas
    11.20.1 Astellas Company Detail
    11.20.2 Astellas Business Overview
    11.20.3 Astellas Pharma and Health Care Introduction
    11.20.4 Astellas Revenue in Pharma and Health Care Business (2017-2022)
    11.20.5 Astellas Recent Development
    13 Report Conclusion
    14 Disclaimer
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
connect with us